Literature DB >> 16439560

cdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis.

Wei Yue1, Julia Shackelford, Joseph S Pagano.   

Abstract

Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) transactivates EBV genes in latently infected B cells. We have shown that mitotic hyperphosphorylation of EBNA2 suppresses its ability to transactivate the latent membrane protein 1 (LMP1) promoter. In this follow-up study, we identify EBNA2 Ser243 as a phosphorylation site for mitotic cdc2/cyclin B1 kinase. Mutation at Ser243, which mimics constitutive phosphorylation of the protein, decreases endogenous levels of both LMP1 and EBNA2. Moreover, mutation at Ser243 reduces the ability of EBNA2 to transactivate Cp, the promoter for all six EBV EBNA genes. Our data implicate EBNA2 Ser243 as a cdc2/cyclin B1 site of phosphorylation important for EBNA2's cotranscriptional function in mitosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439560      PMCID: PMC1367142          DOI: 10.1128/JVI.80.4.2045-2050.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation.

Authors:  Bogaslaw Kwiatkowski; Szu Yu Jenny Chen; William H Schubach
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.

Authors:  T Lindahl; A Adams; G Bjursell; G W Bornkamm; C Kaschka-Dierich; U Jehn
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

3.  Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cells.

Authors:  W Leibold; T D Flanagan; J Menezes; G Klein
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

4.  Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.

Authors:  J E Shaw; L F Levinger; C W Carter
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

5.  An evaluation of the double thymidine block for synchronizing mammalian cells at the G1-S border.

Authors:  C J Bostock; D M Prescott; J B Kirkpatrick
Journal:  Exp Cell Res       Date:  1971-09       Impact factor: 3.905

6.  Establishment of cell lines from peripheral leucocytes in infectious mononucleosis.

Authors:  J H Pope
Journal:  Nature       Date:  1967-11-25       Impact factor: 49.962

7.  Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.

Authors:  Shunbin Ning; Angela M Hahn; Leslie E Huye; Joseph S Pagano
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses.

Authors:  Sang Yoon Lee; Markus R Wenk; Yong Kim; Angus C Nairn; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

9.  One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain.

Authors:  K Hennessy; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.

Authors:  T Dambaugh; K Hennessy; L Chamnankit; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more
  7 in total

1.  Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting.

Authors:  Henrik Gross; Stephanie Barth; Richard D Palermo; Alfredo Mamiani; Christine Hennard; Ursula Zimber-Strobl; Michelle J West; Elisabeth Kremmer; Friedrich A Grässer
Journal:  Virology       Date:  2009-12-06       Impact factor: 3.616

2.  Aberrant cytoplasmic expression of cyclin B1 protein and its correlation with EBV-LMP1, P53 and P16(INK4A) in classical Hodgkin lymphoma in China.

Authors:  Po Zhao; Yali Lu; Lin Liu; Mei Zhong
Journal:  Pathol Oncol Res       Date:  2010-12-21       Impact factor: 3.201

3.  Phosphorylation events during viral infections provide potential therapeutic targets.

Authors:  Julie A Keating; Rob Striker
Journal:  Rev Med Virol       Date:  2011-11-24       Impact factor: 6.989

4.  RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.

Authors:  Richard D Palermo; Helen M Webb; Michelle J West
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

5.  Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization.

Authors:  Janine Mühe; Fred Wang
Journal:  PLoS Pathog       Date:  2017-12-20       Impact factor: 6.823

Review 6.  The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.

Authors:  Yuyan Wang; Shuvomoy Banerjee; Ling Ding; Cankun Cai; Fang Wei; Qiliang Cai
Journal:  Virol Sin       Date:  2017-10-30       Impact factor: 4.327

7.  PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected mice.

Authors:  Xiang Zhang; Patrick Schuhmachers; André Mourão; Piero Giansanti; Anita Murer; Sybille Thumann; Cornelia Kuklik-Roos; Sophie Beer; Stefanie M Hauck; Wolfgang Hammerschmidt; Ralf Küppers; Bernhard Kuster; Monika Raab; Klaus Strebhardt; Michael Sattler; Christian Münz; Bettina Kempkes
Journal:  EMBO Rep       Date:  2021-10-04       Impact factor: 8.807

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.